Efzofitimod 5 mg/kg

Drug identity checked against registry records

Also recorded as ATYR1923; KRP-R120

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisNCT05415137ATYRPhase 3Completed2025-06-25Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.